ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Device For Glioblastoma Multiforme

April 29, 2011

Funding Opportunities: NCI Request for Applications

April 28, 2000

ACS Cancer Control Research Grant Programs Available

May 5, 2000

FCRC Contract Will Be Completed In Five Parts, Two of Them For Small Business; RFP Available July 24

July 3, 1981

Norris Cotton Cancer Center wins core grant renewal.

October 10, 2003

Also NIH unveils Roadmap initiatives, releases four RFAs; Director Zerhouni defends peer review before House, Senate oversight committees, seeks greater authority for trans-NIH initiatives.

October 3, 2003